FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1327206 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
21-hydroxylase deficiency Preferred (foundation metadata concept)
21-hydroxylase deficiency (disorder) Preferred (foundation metadata concept)
21-hydroxylase deficiency, salt wasting type Acceptable (foundation metadata concept)
21-hydroxyprogesterone Acceptable (foundation metadata concept)
21-hydroxysteroid dehydrogenase (NADP^+^) Preferred (foundation metadata concept)
21-hydroxysteroid dehydrogenase (NAD^+^) Preferred (foundation metadata concept)
21-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide ^+^) Acceptable (foundation metadata concept)
21-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide ^+^) (substance) Preferred (foundation metadata concept)
21-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) Acceptable (foundation metadata concept)
21-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) (substance) Preferred (foundation metadata concept)
21.7 Preferred (foundation metadata concept)
21.7 (qualifier value) Preferred (foundation metadata concept)
21/2 inch Preferred (foundation metadata concept)
21/2 inch (qualifier value) Preferred (foundation metadata concept)
21/25 Preferred (foundation metadata concept)
210 Preferred (foundation metadata concept)
210 (AJCC) Acceptable (foundation metadata concept)
210 (UICC) Acceptable (foundation metadata concept)
210 (qualifier value) Preferred (foundation metadata concept)
210 minute plasma GH level Preferred (foundation metadata concept)
210 minute plasma GH level Preferred (foundation metadata concept)
210 minute plasma GH level Acceptable (foundation metadata concept)
210 minute plasma GH level (procedure) Preferred (foundation metadata concept)
210 minute plasma GH level (procedure) Preferred (foundation metadata concept)
210 minute plasma GH measurement Preferred (foundation metadata concept)
210 minute plasma cortisol level Acceptable (foundation metadata concept)
210 minute plasma cortisol level Preferred (foundation metadata concept)
210 minute plasma cortisol level Preferred (foundation metadata concept)
210 minute plasma cortisol level (procedure) Preferred (foundation metadata concept)
210 minute plasma cortisol level (procedure) Preferred (foundation metadata concept)
210 minute plasma cortisol measurement Preferred (foundation metadata concept)
210 minute plasma cortisol measurement (procedure) Preferred (foundation metadata concept)
210 minute plasma growth hormone measurement Acceptable (foundation metadata concept)
210 minute plasma growth hormone measurement (procedure) Preferred (foundation metadata concept)
210 minute serum GH level Preferred (foundation metadata concept)
210 minute serum GH level Preferred (foundation metadata concept)
210 minute serum GH level Acceptable (foundation metadata concept)
210 minute serum GH level (procedure) Preferred (foundation metadata concept)
210 minute serum GH level (procedure) Preferred (foundation metadata concept)
210 minute serum GH measurement Preferred (foundation metadata concept)
210 minute serum cortisol level Preferred (foundation metadata concept)
210 minute serum cortisol level Preferred (foundation metadata concept)
210 minute serum cortisol level Acceptable (foundation metadata concept)
210 minute serum cortisol level (procedure) Preferred (foundation metadata concept)
210 minute serum cortisol level (procedure) Preferred (foundation metadata concept)
210 minute serum cortisol measurement Preferred (foundation metadata concept)
210 minute serum cortisol measurement (procedure) Preferred (foundation metadata concept)
210 minute serum growth hormone measurement Acceptable (foundation metadata concept)
210 minute serum growth hormone measurement (procedure) Preferred (foundation metadata concept)
210-Bi Acceptable (foundation metadata concept)
210-Pb Acceptable (foundation metadata concept)
210-Rn Acceptable (foundation metadata concept)
210-Tl Acceptable (foundation metadata concept)
210m-Bi Acceptable (foundation metadata concept)
211 (AJCC) Acceptable (foundation metadata concept)
211 (UICC) Acceptable (foundation metadata concept)
211-Bi Acceptable (foundation metadata concept)
211-Pb Acceptable (foundation metadata concept)
211-Rn Acceptable (foundation metadata concept)
212 (AJCC) Acceptable (foundation metadata concept)
212 (UICC) Acceptable (foundation metadata concept)
212-Pb Acceptable (foundation metadata concept)
213 (AJCC) Acceptable (foundation metadata concept)
213 (UICC) Acceptable (foundation metadata concept)
214 (AJCC) Acceptable (foundation metadata concept)
214 (UICC) Acceptable (foundation metadata concept)
214-Pb Acceptable (foundation metadata concept)
215 Preferred (foundation metadata concept)
215 (AJCC) Acceptable (foundation metadata concept)
215 (UICC) Acceptable (foundation metadata concept)
215 (qualifier value) Preferred (foundation metadata concept)
216 Preferred (foundation metadata concept)
216 (AJCC) Acceptable (foundation metadata concept)
216 (UICC) Acceptable (foundation metadata concept)
216 (qualifier value) Preferred (foundation metadata concept)
217 Preferred (foundation metadata concept)
217 (AJCC) Acceptable (foundation metadata concept)
217 (UICC) Acceptable (foundation metadata concept)
217 (qualifier value) Preferred (foundation metadata concept)
218 Preferred (foundation metadata concept)
218 (AJCC) Acceptable (foundation metadata concept)
218 (UICC) Acceptable (foundation metadata concept)
218 (qualifier value) Preferred (foundation metadata concept)
218-Rn Acceptable (foundation metadata concept)
219 Preferred (foundation metadata concept)
219 (AJCC) Acceptable (foundation metadata concept)
219 (UICC) Acceptable (foundation metadata concept)
219 (qualifier value) Preferred (foundation metadata concept)
219-Ra Acceptable (foundation metadata concept)
21G Preferred (foundation metadata concept)
21G (qualifier value) Preferred (foundation metadata concept)
21q partial distal trisomy Preferred (foundation metadata concept)
21q partial distal trisomy (disorder) Preferred (foundation metadata concept)
21q partial monosomy syndrome Preferred (foundation metadata concept)
21q partial monosomy syndrome (disorder) Preferred (foundation metadata concept)
21q partial proximal monosomy syndrome Acceptable (foundation metadata concept)
21q partial trisomy Preferred (foundation metadata concept)
21q partial trisomy (disorder) Preferred (foundation metadata concept)
21q partial trisomy syndrome Preferred (foundation metadata concept)
21q partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
21q22.11q22.12 microdeletion syndrome Preferred (foundation metadata concept)

Start Previous Page 91 of 13273 Next End


Reference Sets

Reference set descriptor

Back to Start